Updated:
Emerging Longevity Ventures
Emerging Longevity Ventures is a venture capital firm that focuses on biotechnology investments. It has made one investment, deploying $5 million in total...
Emerging Longevity Ventures
Emerging Longevity Ventures is a venture capital firm that focuses on biotechnology investments. It has made one investment, deploying $5 million in total capital.
General information
Firm type
Venture Capital
Year founded
2017
Location
Region
North America
Country
United States
City
Mountain View
Corporate office
Mountain View, CA, United States
Additional offices
San Diego, CA, United States
Sector focus
Frequently asked questions
What investment stages does Emerging Longevity Ventures typically target?
The firm focuses on early-stage companies, based on its sector tags and typical venture capital posture. No specific stage ranges (e.g., seed, Series A) have been publicly confirmed.
What is Emerging Longevity Ventures' known posture on co-investments alongside external GPs?
Co-investment practices are not publicly documented. Without confirmed portfolio companies or partnerships, the firm's co-investment posture remains unknown.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: